466OASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test. (25th November 2018) - Freitas, H C; Park, K; Kim, D-W; Tiseo, M; Hochmair, M J; Chang, G-C; Shi, Y-K; Moran, T; Chen, Y; Laskin, J; Solomon, B; Miranda, M; et al.